An evaluation of benznidazole as a Chagas disease therapeutic-Reference-Cited by-同舟云学术

An evaluation of benznidazole as a Chagas disease therapeutic

Published:2019-08-28 Issue:15 Volume:20 Page:1797-1807
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Caldas Ivo S.¹,Santos Elda G.²,Novaes Rômulo D.²

Affiliation:

1. Department of Pathology and Parasitology, Institute of Biomedical Sciences, Universidade Federal de Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil

2. Department of Structural Biology, Institute of Biomedical Sciences, Universidade Federal de Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1650915

Reference101 articles.

1. Chagas disease

2. WHO, World health organization: Chagas disease (American trypanosomiasis). Accessed May 01, 2019. https://www.who.int/chagas/home_more/en/

3. Chagas disease in Europe: A review for the internist in the globalized world

4. American Trypanosomiasis (Chagas Disease)

5. Challenges of immunosuppressive and antitrypanosomal drug therapy after heart transplantation in patients with chronic Chagas disease: A systematic review of clinical recommendations

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mitochondrial uncoupler 2,4-dinitrophenol modulates inflammatory and oxidative responses in Trypanosoma cruzi-induced acute myocarditis in mice;Cardiovascular Pathology;2024-09

2. Identification of host antioxidant effectors as thioridazine targets: Impact on cardiomyocytes infection and Trypanosoma cruzi-induced acute myocarditis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-08

3. The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis;Pharmaceutics;2024-02-04

4. Schistosoma mansoni co-infection modulates Chagas disease development but does not impair the effect of benznidazole-based chemotherapy;International Immunopharmacology;2024-02

5. Evaluation of parasitemia by qPCR in patients with chronic Chagas disease treated with benznidazole;Asian Pacific Journal of Tropical Medicine;2023-12